Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABT | Common shares without par value | Award | $0 | +10.6K | +22.6% | $0.00 | 57.3K | Feb 17, 2023 | Direct | F1 |
holding | ABT | Common shares without par value | 2.43K | Feb 17, 2023 | Profit Sharing Trust | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABT | Option (right to buy) | Award | $0 | +41.6K | $0.00 | 41.6K | Feb 17, 2023 | Common Shares | 41.6K | $106.24 | Direct | F3 |
Id | Content |
---|---|
F1 | These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. |
F2 | Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2023. |
F3 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,882 on February 17, 2024, 13,883 on February 17, 2025, and 13,883 on February 17, 2026. |